Pharmaceutical, Biological and Chemical Patents - A Handbook

Germany is a leading venue for patent litigation, with about 60% of European patent cases heard in its courts. Especially in pharmaceutical, biological, and chemical patents, German case law provides key interpretations and legal guidance, notably on issues like 'state of the art' and substance identification. This handbook highlights core principles and trends in German jurisprudence to support arguments across jurisdictions.Advantages at a glance:

Structured overview of German patent law

English translations of major rulings

Focus on pharma, bio, and chemical patent issues

Zusammenfassung

Germany is a leading venue for patent litigation, with about 60% of European patent cases heard in its courts. Especially in pharmaceutical, biological, and chemical patents, German case law provides key interpretations and legal guidance, notably on issues like ‘state of the art’ and substance identification. This handbook highlights core principles and trends in German jurisprudence to support arguments across jurisdictions.

Advantages at a glance:
Structured overview of German patent law
English translations of major rulings
Focus on pharma, bio, and chemical patent issues

Produktdetails

• Autoren: Dirk Bühler, Maximilia Haedicke, Maximilian Haedicke, Marc Stief, Marco Stief, Annelie Wünsche
• Verlag: Nomos
• Sprache: Englisch, Deutsch
• Produktform: Fester Einband
• Erscheint: 01.12.2025
• EAN: 9783848703005
• ISBN: 978-3-8487-0300-5
• Seiten: 1200
• Serie: Kooperationswerke Beck - Hart
• Thema: Sozialwissenschaften, Recht,Wirtschaft > Recht > Internationales Recht, Ausländisches Recht